News from galderma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Sep 14, 2018, 19:04 ET Expertos reclaman una mejor identificación de pacientes con alta carga de rosácea en la práctica diaria

El análisis adicional de un estudio global realizado y presentado este año, el informe de especialistas llamado 'Rosacea: Beyond the visible'...


Sep 14, 2018, 13:36 ET Especialistas solicitam melhoria na identificação de pacientes com 'alto grau' de rosácea na prática diária

Uma análise adicional de uma pesquisa global conduzida e apresentada no início desse ano, como um relatório de autoria de especialistas, intitulado...


Sep 14, 2018, 07:04 ET Experts Call for Improved Identification of 'High Burden' Rosacea Patients in Everyday Practice

Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone...


Jun 01, 2018, 06:11 ET Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look 'Beyond the visible'

Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with...


May 07, 2018, 08:00 ET Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne

Galderma, a global leader focused on medical solutions for skin health, announces the publication of results from the Phase 4 ALAMO study, which...


Apr 30, 2018, 08:00 ET New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients

Galderma, a global leader focused on medical solutions for skin health, announces positive results from OSCAR, a phase 4 trial, a multicenter,...


Feb 21, 2018, 08:00 ET Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products

Nestlé Skin Health and its medical solutions business, Galderma, are excited to announce the introduction of Differin Daily Deep Cleanser and...


Oct 18, 2017, 10:44 ET Fort Worth's Galderma, Maker of Cetaphil, Draws 524 Runners to Wonder Run 5k and 1K Kids Waddle to Benefit Children's Skin Disease Foundation

Galderma, a Nestlé Skin Health company and maker of Cetaphil, the #1 dermatologist-recommended brand of cleansers and moisturizers, served as lead...


Oct 12, 2017, 09:00 ET Galderma Announces FDA Approval of Restylane® Silk as the First HA Dermal Filler Approved for Injection via Cannula

Galderma, a global leader focused on medical solutions in skin health, announced today it has received U.S. Food and Drug Administration (FDA)...


Sep 16, 2017, 07:56 ET Galderma: 'Clear' (IGA 0) Rosacea Patients Experience a Delayed Time to Relapse

Today, the results of a pooled analysis of four Galderma-sponsored studies evaluating the use of topical therapies for the treatment of inflammatory...


Sep 11, 2017, 04:13 ET Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study

Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published...


Sep 07, 2017, 13:24 ET Galderma Names Chris Chapman to Oversee Prescription Business Unit

Galderma, a global leader focused on medical solutions in skin health, has appointed Chris Chapman as the company's new Vice President and General...


Sep 07, 2017, 09:00 ET Galderma Names Alisa Lask to Oversee Aesthetic & Corrective Business Unit

Galderma, based in Fort Worth, is the medical solutions business of Nestlé Skin Health. Galderma has appointed Alisa Lask as the company's new Vice...


Aug 10, 2017, 15:41 ET Fort Worth-Based Galderma Donates 1,600 Backpacks Filled with Schools Supplies to Northwest ISD Students

Galderma is continuing its commitment to the local community by donating 1,600 backpacks filled with school supplies to Northwest ISD students in...


Jun 15, 2017, 09:48 ET Galderma, Maker of Cetaphil Moisturizers and Cleansers, Continues Partnership with Camp Wonder

Fort Worth's Galderma, a Nestlé Skin Health company and maker of Cetaphil, the #1 dermatologist-recommended brand of cleansers and moisturizers, is...


Apr 06, 2017, 13:09 ET Galderma Presents Results From Phase 4 Clinical Studies of Restylane® Refyne and Restylane® Defyne at the 15th Aesthetic & Anti-aging Medicine Annual World Congress

Galderma, a global leader focused on medical solutions in skin health, announced today the results from two Phase 4 clinical studies of its most...


Mar 08, 2017, 07:05 ET Cetaphil® Expands Skincare Portfolio to Include Seven New Facial Care Products in 2017

Galderma Laboratories, L.P., makers of Cetaphil®, a brand recommended by more dermatologists than any other brand of cleansers and moisturizers, is...


Mar 02, 2017, 07:55 ET Galderma Announces Skincare Collaboration with Colorescience®

Galderma, a global leader in medical solutions for skin health, is proud to announce a collaboration with Colorescience, the leading...


Feb 01, 2017, 07:05 ET Differin® Gel Acne Treatment Partners with Actress Ashley Benson to End Adult Acne Frustrations for Millions of Sufferers

Galderma, a global leader focused on medical solutions in skin health, announced today that they have partnered with actress Ashley Benson to...


Dec 12, 2016, 07:55 ET Galderma Announces FDA Approval of Restylane® Refyne and Restylane® Defyne Dermal Fillers for Treatment of "Laugh Lines"

Galderma, a global leader focused on medical solutions in skin health, announced today it has received U.S. Food and Drug Administration (FDA)...


Nov 10, 2016, 08:55 ET Galderma to Share Data from Phase 3 Studies of New Investigational Restylane® Refyne and Restylane® Defyne at American Society for Dermatologic Surgery Annual Meeting

Galderma, a global leader focused on medical solutions in skin health, will share data from two pivotal Phase 3 clinical studies investigating...


Sep 28, 2016, 07:12 ET Galderma erhält positive Stellungnahme im europäischen dezentralisierten Verfahren für die Zulassung von EPIDUO® 0,3% / 2,5% Gel (Adapalen / Benzoylperoxid) zur Behandlung von Akne[1]

Das Unternehmen Galderma gab heute bekannt, dass es eine positive Stellungnahme der 16 betroffenen Regelungsbehörden[2] für die Marktzulassung von...


Sep 28, 2016, 07:11 ET Galderma reçoit, dans le cadre d'une procédure européenne décentralisée, un avis positif pour l'homologation d'EPIDUO® 0,3 % / 2,5 % Gel (adapalène / peroxyde de benzoyle) pour traiter les patients atteints d'acné[1]

Galderma a annoncé aujourd'hui avoir reçu un avis positif de 16 agences de réglementation européennes concernées[2] pour l'autorisation de mise sur...


Sep 28, 2016, 01:43 ET Galderma recibe la opinión positiva para la aprobación de EPIDUO® 0,3% / 2,5% en gel para el acné

-Galderma recibe la opinión positiva mediante un procedimiento descentralizado europeo para la aprobación de EPIDUO® 0,3% / 2,5% en gel (adapaleno /...


Jul 08, 2016, 12:45 ET Galderma Announces FDA Approval of Full Prescription-Strength Differin® Gel For Over-the-Counter Acne Use

Galderma, a global leader focused on medical solutions in skin health, today announced that its U.S. affiliate, Galderma Laboratories, L.P. received...